Newsletter | February 11, 2026

02.11.26 -- Do's And Don'ts Of Material Handling When Retrofitting For ADCs

FOCUS ON DOWNSTREAM MANUFACTURING

Do's And Don'ts Of Material Handling When Retrofitting For ADCs

Antibody-drug conjugate manufacturing includes extremely dangerous ingredients, and most legacy facilities lack the features and flows for safe handling.

Benefits Of Isolator Technology In Fill-Finish

Isolator technology enhances sterility assurance, reduces contamination risk, improves operator safety, and supports regulatory compliance, making it essential for modern aseptic fill-finish operations.

Intensifying Downstream Bioprocessing With Continuous Technologies

Watch to explore intensified downstream bioprocessing in-depth and take the first step toward a more innovative and efficient future in bioprocessing.

The Effect Of Mixing Homogeneity In Retentate Vessel

Discover a novel analytical method enhancing TFF diafiltration insights that deliver superior mixing, reliable scale-up, and breakthrough interpretation of diavolume performance.

From Bottlenecks To Breakthroughs: Mastering Buffer Management

Traditional process of liquid and buffer manufacturing have been shown to be resource intensive. Examine strategies to overcome buffer-related bottlenecks in large-scale biomanufacturing.

Considerations For High Productivity Membrane Affinity Chromatography

Review results from a study aiming to identify hydrodynamic shear rate, cumulative shear stress, and Reynolds number values likely in high-productivity affinity membrane chromatography.

DOWNSTREAM MANUFACTURING SOLUTIONS

Fully Automated Single-Use Continuous Chromatography Capture - MilliporeSigma

Multitools For Clarification And Harvest - CARR Biosystems

Overview Of Solutions Across The Entire Downstream Workflow - Cytiva

SPONSOR

Webinar: Four Common Pitfalls to Avoid in UF/DF Setup and Scale-Up

UF/DF scale-up shouldn’t be where good processes fall apart. In this Repligen webinar, uncover four costly UF/DF pitfalls that derail programs—from membrane selection missteps to manual-heavy systems and PD–MSAT disconnects. Learn how early decisions impact scalability, timelines, and risk, and walk away with actionable strategies to build robust UF/DF processes that transfer smoothly to manufacturing. Click here to learn more.

FOCUS ON FILL-FINISH

How To Reduce Five Key Risks In Fill and Finish

Common fill-finish risks include human error, process variability, contamination, product inconsistency, and more. Observe best practice solutions for manufacturers looking to de-risk this process.

Key Topics And Trends In Aseptic Filling

Aseptic filling is vital yet often guided by outdated practices. Read expert insights on modern technologies, evolving regulations, and data-driven strategies to improve compliance and reduce risk.

FILL-FINISH SOLUTIONS

Ready‑To‑Use Cryopreservation Media For Cells And Tissues - Miltenyi Biotec

Prefilled Syringe Plungers: Mitigating Risk for Success - West Pharmaceutical Services, Inc

Connect With Bioprocess Online: